Performance of a quality control center supporting national antimicrobial resistance surveillance - Report - MDSpire

Performance of a quality control center supporting national antimicrobial resistance surveillance

  • By

  • Dong Woo Shin

  • Hyunji Kim

  • Jeong Su Park

  • Kyoung Un Park

  • Min Hyuk Choi

  • Dokyun Kim

  • Seok Hoon Jeong

  • Hee Jung Kim

  • Young Ah Kim

  • Kwangjin Ahn

  • Young Uh

  • Yong Jun Kwon

  • Jong Hee Shin

  • Soo Hyun Kim

  • Jeong Hwan Shin

  • Hee Young Kang

  • Dong Chan Moon

  • Sung Young Lee

  • Songmee Bae

  • June 3, 2026

  • 0 min

Share

Effectiveness of a Quality Control Center in Enhancing National Antimicrobial Resistance Monitoring

Overview

The study evaluates the performance of a centralized quality control center (QCC) in maintaining high standards of antimicrobial resistance (AMR) surveillance in South Korea's Kor-GLASS system. Results indicate that interlaboratory proficiency testing (IPT) consistently exceeded 97% categorical agreement, with no external quality assessment (EQA) failures observed.

Background

Antimicrobial resistance (AMR) poses a significant global health threat, with millions of infections and deaths attributed to resistant pathogens annually. Reliable AMR surveillance data is crucial for public health responses, necessitating robust quality assurance frameworks. The Kor-GLASS system in South Korea aims to provide standardized AMR data, supported by a QCC to ensure data quality and comparability.

Data Highlights

Assessment TypePerformance MetricResult
Interlaboratory Proficiency Testing (IPT)Categorical Agreement (CA)Exceeds 97%
External Quality Assessment (EQA)FailuresNone

Key Findings

  • Overall CA in IPT consistently exceeded 97% across the study period.
  • No EQA failures were observed among participating centers.
  • Major errors in Phase II were primarily due to AST reading and near-breakpoint discrepancies.
  • Frequency of major errors decreased in Phase III following corrective actions and educational interventions.
  • High concordance in ceftazidime-avibactam susceptibility testing was noted, with rare discrepancies.
  • Interlaboratory validation confirmed acceptable performance for AST of Haemophilus spp.

Clinical Implications

The findings support the importance of a centralized QCC in maintaining high-quality AMR surveillance. Continuous quality assurance activities are essential for ensuring the reliability of laboratory data and enhancing public health responses to AMR.

Conclusion

The study demonstrates that a QCC can effectively sustain reliable AMR surveillance performance during system expansion, reinforcing the credibility of AMR data generation.

Related Resources & Content

  1. Open Forum Infectious Diseases, 2023 -- Antifungal Resistance Surveillance: Insights From National Mycology Reference Centers and Expert Mycology Laboratories
  2. Critical Care, 2023 -- Optimal antibiotic use in the intensive care unit
  3. American Journal of Epidemiology, 2023 -- Monitoring Antibiotic-Resistant Bacteria in Wastewater: Opportunities and Obstacles for Public Health Initiatives
  4. Infection, 2023 -- Strategies for Preventing and Controlling Infections Caused by Multidrug-Resistant Organisms: A Systematic Review and Network Meta-Analysis
  5. Global antibiotic resistance surveillance report 2025, WHO -- Global antibiotic resistance surveillance report 2025
  6. External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2024, ECDC -- External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2024
  7. Press Release, KDCA -- Press Release
  8. Global antibiotic resistance surveillance report 2025
  9. External quality assessment (EQA) of performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net)
  10. Press Release

Original Source(s)

Related Content